BioPharma Credit PLC (BPCR)

Currency in USD
0.864
-0.008(-0.92%)
Closed·
BPCR Scorecard
Full Analysis
Management has been aggressively buying back shares
High dividend Yield
BPCR is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
0.8640.876
52 wk Range
0.8000.910
Key Statistics
Bid/Ask
0.836 / 0.91
Prev. Close
0.872
Open
0.876
Day's Range
0.864-0.876
52 wk Range
0.8-0.91
Volume
224.39K
Average Volume (3m)
750.99K
1-Year Change
0.46%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BPCR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

BioPharma Credit PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

BioPharma Credit PLC Company Profile

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. The company debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in Leeds, the United Kingdom.

Compare BPCR to Peers and Sector

Metrics to compare
BPCR
Peers
Sector
Relationship
P/E Ratio
8.1x27.4x9.5x
PEG Ratio
0.390.400.03
Price/Book
0.8x3.4x1.0x
Price / LTM Sales
6.6x5.3x2.8x
Upside (Analyst Target)
-21.9%13.2%
Fair Value Upside
Unlock14.3%1.8%Unlock

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 0.000

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.10%
Dividend Yield
11.78%
Industry Median 2.77%
Annualised payout
0.10
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Mar 25, 2025
EPS / Forecast
0.04 / --
Revenue / Forecast
70.89M / --
EPS Revisions
Last 90 days

BPCR Income Statement

People Also Watch

154.00
CAML
+2.39%
295.40
SBRY
-0.34%
228.50
HFEL
0.00%
13.600
MTL
+1.87%

FAQ

What Stock Exchange Does BioPharma Credit Trade On?

BioPharma Credit is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for BioPharma Credit?

The stock symbol for BioPharma Credit is "BPCR."

What Is the BioPharma Credit Market Cap?

As of today, BioPharma Credit market cap is 978.00M.

What Is BioPharma Credit's Earnings Per Share (TTM)?

The BioPharma Credit EPS (TTM) is 0.10.

From a Technical Analysis Perspective, Is BPCR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has BioPharma Credit Stock Split?

BioPharma Credit has split 0 times.

How Many Employees Does BioPharma Credit Have?

BioPharma Credit has 0 employees.

What is the current trading status of BioPharma Credit (BPCR)?

As of 06 Aug 2025, BioPharma Credit (BPCR) is trading at a price of 0.86, with a previous close of 0.87. The stock has fluctuated within a day range of 0.86 to 0.88, while its 52-week range spans from 0.80 to 0.91.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.